Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study. [electronic resource]
Producer: 20201112Description: e012244 p. digitalISSN:- 2047-9980
- Adrenergic beta-Antagonists -- therapeutic use
- Aged
- Angiotensin Receptor Antagonists -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Cardiovascular Diseases -- complications
- Cholesterol, LDL
- Diabetes Mellitus, Type 2 -- complications
- Dual Anti-Platelet Therapy
- Female
- Glycated Hemoglobin -- metabolism
- Heart Failure -- complications
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypoglycemic Agents -- therapeutic use
- Italy
- Male
- Metformin -- therapeutic use
- Middle Aged
- Myocardial Infarction -- complications
- Myocardial Ischemia -- complications
- Myocardial Revascularization
- Practice Patterns, Physicians' -- statistics & numerical data
- Sodium Potassium Chloride Symporter Inhibitors -- therapeutic use
- Sodium-Glucose Transporter 2 Inhibitors -- therapeutic use
- Glucagon-Like Peptide-1 Receptor Agonists
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.